Citations for
1FRMD5, NEDEMA, ROCK1
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement
Lu S, Ma M, Mao X, Bacino CA, Jankovic J, Sutton VR, Bartley JA, Wang X, Rosenfeld JA, Beleza-Meireles A, Chauhan J, Pan X, Li M, Liu P, Prescott K, Amin S, Davies G, Wangler MF, Dai Y, Bellen HJ.
Am J Hum Genet. Oct 6;109(10):1932-1943. doi: 10.1016/j.ajhg.2022.09.005. 2022
2FRMD5, TCF7L2
Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex
Zhu C, Yamaguchi K, Ohsugi T, Terakado Y, Noguchi R, Ikenoue T, Furukawa Y.
Cancer Sci. Apr;108(4):612-619. doi: 10.1111/cas.13174. Epub 2017 Apr 20. 2017
3FRMD5, ROCK1
FERM domain-containing protein FRMD5 regulates cell motility via binding to integrin β5 subunit and ROCK1
Hu J, Niu M, Li X, Lu D, Cui J, Xu W, Li G, Zhan J, Zhang H.
FEBS Lett. Nov 28;588(23):4348-56. doi: 10.1016/j.febslet.2014.10.012. Epub 2014 Oct 18 2014
4CTNND1, FRMD5
FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression
Wang T, Pei X, Zhan J, Hu J, Yu Y, Zhang H.
FEBS Lett. Sep 21;586(19):3044-50. doi: 10.1016/j.febslet.2012.07.019. Epub 2012 Jul 27. 2012